MultiCell Technologies, Inc.(Other OTC/NBB : MCET)
MCET PreMarket: $ () as of AM
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Health Technology » Biotechnology
MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. Its therapeutic development platform includes several patented techniques used to isolate, characterize and differentiate stem cells from human liver or control the immune response at transcriptional and translational levels through dsRNA-sensing molecules, such as Toll-like receptor, RIG-I-like receptor, and MDA-5 signaling. The company was founded on April 28, 1970 and is headquartered in Woonsocket, RI.